POLYPROX

PolyProx Therapeutics is developer of a novel class of drug intended to provide new therapies for cancer treatment. The company's drug will use novel engineered protein that is able to selectively target tumour cells and trigger natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and remove disease-causing proteins.

#SimilarOrganizations #People #Financial #Website #More

POLYPROX

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

2019-01-01

Address:

Cambridge, Cambridgeshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.polyprox.com

Total Employee:

Status:

Active

Contact:

+44 (0)1223 804 420

Email Addresses:

[email protected]

Total Funding:

4.4 M GBP

Technology used in webpage:

Pound Sterling GoDaddy

Similar Organizations

phico-therapeutics-logo

Phico Therapeutics

Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.

Current Employees Featured

andrew-p-sandham_image

Andrew P Sandham
Andrew P Sandham Executive Chairman @ PolyProx
Executive Chairman

laura-s-itzhaki_image

Laura S Itzhaki
Laura S Itzhaki Founder and Chief Scientific Officer @ PolyProx
Founder and Chief Scientific Officer

Founder

laura-s-itzhaki_image

Laura S Itzhaki

Investors List

lifearc_image

Official Site Inspections

http://www.polyprox.com

Host Informations
Whois Informations

Loading ...